These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 23888685

  • 1. [The development of co-amorphous drug systems].
    Yao J, Shi NQ, Wang XL.
    Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
    [Abstract] [Full Text] [Related]

  • 2. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW, Löbmann K, Grohganz H, Rades T, Chieng N.
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [Abstract] [Full Text] [Related]

  • 3. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N, Aaltonen J, Saville D, Rades T.
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [Abstract] [Full Text] [Related]

  • 4. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K, Laitinen R, Grohganz H, Gordon KC, Strachan C, Rades T.
    Mol Pharm; 2011 Oct 03; 8(5):1919-28. PubMed ID: 21815614
    [Abstract] [Full Text] [Related]

  • 5. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A.
    Eur J Pharm Biopharm; 2013 Nov 04; 85(3 Pt B):942-51. PubMed ID: 24075980
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
    Kasten G, Lobo L, Dengale S, Grohganz H, Rades T, Löbmann K.
    Eur J Pharm Biopharm; 2018 Nov 04; 132():192-199. PubMed ID: 30266670
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Spray drying of poorly soluble drugs from aqueous arginine solution.
    Ojarinta R, Lerminiaux L, Laitinen R.
    Int J Pharm; 2017 Oct 30; 532(1):289-298. PubMed ID: 28890173
    [Abstract] [Full Text] [Related]

  • 19. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
    Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T.
    J Pharm Sci; 2005 Sep 30; 94(9):1998-2012. PubMed ID: 16052554
    [Abstract] [Full Text] [Related]

  • 20. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ, Shah NH, Sandhu HK, Malick AW, Zia H.
    J Pharm Sci; 2008 Jun 30; 97(6):2286-98. PubMed ID: 17879977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.